CANDEL THERAPEUTICS, INC. (CADL) valuation
Share price $4.90 · As of last filing 2026-03-31
Special situation detected — historical normalisation may not reflect go-forward economics.
EPV and Reverse-DCF outputs below are anchored on history that
no longer represents the entity going forward
(net cash > 50% of market cap)
.
Inspect the balance sheet, recent 8-K filings, and the cards
above before relying on these models.
- net cash > 50% of market cap. Net cash $192.0M (cash $194.8M − debt $2.8M) = 53.5% of market cap $359.0M